Price $9.40 |
Market Cap
419.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
27.1
|
P/B
6.73
|
P/S
2.82
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
46.5
|
Op. Cash Flow
13.7K
|
FCF
0.2
|
|
Op. Margin
14.50%
|
Net Margin
10.80%
|
ROE
24.70%
|
ROI
23.00%
|
|
ROA
14.10%
|
EPS Growth
0.60%
|
Current Ratio
3.3
|
Debt/Equity
8.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Puma Biotechnology Inc (PBYI) | $3.19 | - | - | 133.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $8.14 | - | - | 2.78B | Strong Buy |
| Baudax Bio Inc (BXRX) | $0.54 | - | - | 4.4M | Strong Buy |
| Spero Therapeutics Inc (SPRO) | $1.77 | - | - | 74.6M | Strong Buy |
| Lifecore Biomedical Inc (LFCR) | $7.94 | - | - | 114.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
